Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preventive Antibiotics in Acute Stroke
NL-OMON38262Phase 3Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ceftriaxone in stroke (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Primary efficacy endpoint. Started Jul 2010; status: active, not recruiting.
02
Drugs
ceftriaxone
03
Conditions
stroke
Beyond the preview
Go deeper on NL-OMON38262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38262.